Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2023-05-25 Capital/Financing Update
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Press Release
Capital/Financing Update Classification · 90% confidence The document is a press release dated May 25, 2023, announcing the launch of a new Satellite Laboratory by Lupin Diagnostics in Vijayawada, Andhra Pradesh. It is addressed to stock exchanges as a disclosure pursuant to Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, 2015. The content focuses on business expansion and operational updates rather than financial results, management changes, or regulatory filings. It does not contain financial statements, earnings data, or detailed management discussion. The document is a corporate announcement about business expansion and is not a report or transcript. Therefore, it fits best under the category of Capital/Financing Update (CAP) as it relates to company expansion activities and network growth disclosed to the market under regulatory requirements.
2023-05-25 English
Lupin Diagnostics Launches Satellite Laboratory in Vijayawada.
Capital/Financing Update Classification · 95% confidence The document is a press release dated May 25, 2023, announcing the launch of a new Satellite Laboratory by Lupin Diagnostics in Vijayawada, Andhra Pradesh. It is addressed to stock exchanges as a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs material event disclosures by listed companies. The content focuses on business expansion and operational updates rather than financial results, management changes, or regulatory filings. It does not contain financial statements, earnings data, or detailed management analysis. The document is a corporate announcement about a business development event, fitting the category of Capital/Financing Update (CAP) as it relates to expansion and operational growth disclosed to the market under listing regulations. It is not an earnings release, annual report, or regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-05-25 English
Disclosure in respect of allotment of 36689 shares under ESOP.
Regulatory Filings Classification · 90% confidence The document text is extremely short (568 characters) and consists solely of a digital signature block with no substantive content related to financial performance, management changes, or any report. There is no indication of a report, announcement, or any specific filing type. Given the lack of content and the nature of the text, it does not fit any specific filing category and defaults to Regulatory Filings (RNS) as a fallback category.
2023-05-25 English
ESOP/ESOS/ESPS
Regulatory Filings Classification · 100% confidence The document text is extremely short (514 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no mention of any report type, regulatory body, fiscal period, or corporate event. Given the lack of content and the nature of the text, it does not fit any specific filing category and should be classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit elsewhere.
2023-05-25 English
Transcript of the Q4 FY2023 Earnings Conference Call held at 16.00 hrs (IST)on Wednesday, May 10, 2023.
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q4 FY2023 earnings conference call for Lupin Limited, dated May 10, 2023. It includes management commentary on financial results, business performance, R&D updates, and Q&A with analysts. The presence of detailed financial figures, discussion of quarterly sales, margins, and operational highlights confirms this is a full transcript of an earnings call rather than a brief earnings release or summary. The document explicitly states it is a transcript of the earnings conference call, which matches the definition of a Call Transcript (CT).
2023-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q4 FY2023 earnings conference call for Lupin Limited, dated May 10, 2023. It includes management commentary on financial results, business performance, R&D updates, and Q&A with analysts. The text explicitly states it is a transcript of the earnings call, which is a typical format for Call Transcripts (CT). The document contains detailed financial data and management discussion but is not an official earnings release (ER) or annual/interim report. It is not a brief announcement or a regulatory filing but a full transcript of the call. Therefore, the correct classification is Call Transcript (CT).
2023-05-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.